Bioniche to Present at Rodman & Renshaw 9th Annual Healthcare Conference



    BELLEVILLE, ON, Nov. 6 /CNW/ - Bioniche Life Sciences Inc. (TSX: BNC), a
research-based, technology-driven Canadian biopharmaceutical company, today
announced that Cameron Groome, Executive Vice-President, Corporate & Strategic
Development, will present at the Rodman & Renshaw 9th Annual Global Healthcare
Conference in New York City tomorrow. Mr. Groome will present at 8:30 a.m.
(Eastern Time) in the Holmes II Room of the New York Palace Hotel.
    A live webcast of Bioniche's presentation can be accessed at
http://www.wsw.com/webcast/rrshq12/bnc.to. A replay of the presentation will
be archived for 90 days after the conference. For more information about the
Rodman & Renshaw 9th Annual Healthcare Conference, please visit
http://www.rodmanandrenshaw.com/conferences?id=6.

    About Bioniche Life Sciences Inc.

    Bioniche Life Sciences Inc. is a research-based, technology-driven
Canadian biopharmaceutical company focused on the discovery, development,
manufacturing, and marketing of proprietary products for human and animal
health markets worldwide. The fully-integrated company employs approximately
198 skilled personnel and has three operating divisions: Human Health, Animal
Health, and Food Safety. The Company's primary goal is to develop proprietary
cancer therapies supported by revenues from marketed products in human and
animal health. For more information, please visit www.Bioniche.com.

    Except for historical information, this news release may contain
forward-looking statements that reflect the Company's current expectation
regarding future events. These forward-looking statements involve risk and
uncertainties, which may cause, but are not limited to, changing market
conditions, the successful and timely completion of clinical studies, the
establishment of corporate alliances, the impact of competitive products and
pricing, new product development, uncertainties related to the regulatory
approval process, and other risks detailed from time to time in the Company's
ongoing quarterly and annual reporting.

    %SEDAR: 00013159EF




For further information:

For further information: Jennifer Shea, Corporate Communications &
Investor, Relations Manager, Bioniche Life Sciences Inc., Telephone: (613)
966-8058, Cell: (613) 391-2097, Jennifer.Shea@Bioniche.com

Organization Profile

Telesta Therapeutics Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890